Katarakta klinikiniai tyrimai Texas
7 tyrimai dėl Katarakta ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
- Berkeley Eye Center, Houston
Renkami dalyviai4 fazėLaukiami sveiki savanoriai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06922084A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects
- Berkeley Eye Center - Sugar Land, Sugar Land
Renkami dalyviai4 fazė
Amžius 22 ir vyresni · Visoms lytims · Atnaujinta 2026-07-21 · NCT07693205Clareon TruPlus Study
- Berkeley Eye Center, Sugar Land
Renkami dalyviai
Amžius 22 ir vyresni · Visoms lytims · Atnaujinta 2026-06-03 · NCT07502456IC-8 Apthera IOL New Enrollment Post Approval Study
- Berkeley Eye Center, Sugar Land
Renkami dalyviaiStebimasis tyrimas
Amžius 22 ir vyresni · Visoms lytims · Atnaujinta 2026-01-12 · NCT06060041Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- R and R Eye Research, LLC, San Antonio
Renkami dalyviai3 fazė
Amžius 22 ir vyresni · Visoms lytims · Atnaujinta 2025-10-20 · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Houston Eye Associates, Houston
Renkami dalyviai3 fazė
Amžius 22 ir vyresni · Visoms lytims · Atnaujinta 2025-10-20 · NCT07218783Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Methodist Eye Associates | Houston Methodist, Houston
Renkami dalyviai
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2024-12-03 · NCT05438732Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.